Conduit Pharmaceuticals

Yahoo Finance • 24 days ago

CDT Equity increases bitcoin holding

* CDT Equity (NASDAQ:CDT [https://seekingalpha.com/symbol/CDT]) announced on Friday the acquisition of 9.25648743 Bitcoin (BTC-USD [https://seekingalpha.com/symbol/BTC-USD]) for an aggregate purchase price of $1,005,000, at an average ac... Full story

Yahoo Finance • 24 days ago

CDT Equity Increases Bitcoin Holding

NAPLES, Fla. and CAMBRIDGE, United Kingdom, Oct. 17, 2025 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today announced the acquisition of 9.25648743 Bitcoin (“BTC”) for an aggregate purchase price of $1,005... Full story

Yahoo Finance • last month

CDT Equity announces 1-for-8 reverse stock split effective October 10

* CDT Equity (NASDAQ:CDT [https://seekingalpha.com/symbol/CDT]) to implement a 1-for-8 reverse stock split effective October 10, 2025. * Trading on a split-adjusted basis will begin on October 13, 2025. * Purpose of the split: potent... Full story

Yahoo Finance • last month

CDT Equity Inc. Announces Reverse Stock Split

NAPLES, Fla. and CAMBRIDGE, United Kingdom, Oct. 09, 2025 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), announces that its board of directors has approved a 1-for-8 reverse stock split of the Company’s common... Full story

Yahoo Finance • 2 months ago

CDT Executes Cryptocurrency Treasury Reserve Strategy

NAPLES, Fla. And CAMBRIDGE, United Kingdom, Sept. 17, 2025 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”) today announced the strategic acquisition of 8.65252366 Bitcoin (“BTC”) for an aggregate purchase price... Full story

Yahoo Finance • 2 months ago

Let's take a look at the stocks that are in motion in today's session.

Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top gainers and losers in today's session. [topmovers] TODAY'S TOP GAINERS TICKER CHANGE COMMENT... Full story

Yahoo Finance • 2 months ago

In today's session, these stocks are experiencing unusual volume.

Let's explore the current happenings on the US markets on Tuesday. Below, you'll find the stocks exhibiting unusual volume in today's session. [unusualvolume] TODAY'S UNUSUAL VOLUME STOCKS TICKER CHANGE COMMENT PT [https://ww... Full story

Yahoo Finance • 2 months ago

Top movers analysis one hour before the close of the markets on 2025-09-08: top gainers and losers in today's session.

Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top gainers and losers in today's session. [topmovers] GAINERS TICKER CHANGE COMMENT RAPP [ht... Full story

Yahoo Finance • 2 months ago

Top stock movements in today's session.

Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements. [topmovers] TOP GAINERS TICKER CHANGE COMMENT RAPP [https://www.chartmill.com/stock/quote/RAPP/profile] 111.0%... Full story

Yahoo Finance • 2 months ago

Let's uncover which stocks are experiencing notable gaps during today's session.

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Monday. [gap] GAP UP STOCKS TICKER CHANGE COMMENT XAIR [https://www.chartmill.com/stock/quote/XAIR/profile] 88.24%... Full story

Yahoo Finance • 2 months ago

Top movers in Monday's pre-market session

Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session. [premarket] TODAY'S PRE-MARKET GAINERS TICKER CHANGE COMMENT HOUR [https://www.ch... Full story

Yahoo Finance • 3 months ago

CDT Equity says March 2025 financials can no longer be relied upon due to restatement

CDT Equity Inc. (NASDAQ:CDT), a company currently valued at $5.33 million and showing weak financial health according to InvestingPro analysis, announced Thursday that its previously issued unaudited financial statements for the quarter en... Full story

Yahoo Finance • 3 months ago

PIMCO Income Strategy Fund II declares $0.0718 dividend

* PIMCO Income Strategy Fund II (PFN ) declares $0.0718/share monthly dividend [https://seekingalpha.com/pr/20186905-pimco-closed-end-funds-declare-monthly-common-share-distributions]. * Payable Sept. 2; for shareholders of record Aug.... Full story

Yahoo Finance • 4 months ago

Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries

Includes Conduit’s first composition of matter patent filing for AZD5658 and multiple new combination filings for AZD1656 and AZD5658Patents derived from AI-led analysis conducted in partnership with Sarborg Limited NAPLES, Fla. and CAMBR... Full story

Yahoo Finance • 6 months ago

Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market

NAPLES, Fla. and CAMBRIDGE, United Kingdom, May 22, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), a dynamic, multi-asset clinical stage, life science company delivering an efficient mod... Full story

Yahoo Finance • 6 months ago

Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance

Conduit regains compliance with Bid Price and Equity RequirementsCDT will continue to be listed and traded on The Nasdaq Stock Market NAPLES, Fla. and CAMBRIDGE, United Kingdom, May 21, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals I... Full story

Yahoo Finance • 6 months ago

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split

NAPLES, Fla. and CAMBRIDGE, United Kingdom, May 16, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), a dynamic, multi-asset clinical stage, life science company delivering an efficient mod... Full story

Yahoo Finance • 7 months ago

Conduit Pharmaceuticals Announces Leadership Changes

NAPLES, Fla. and CAMBRIDGE, United Kingdom, April 16, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ("Conduit Pharmaceuticals" or "Conduit" or the "Company") today announced key leadership changes to support the com... Full story

Yahoo Finance • 7 months ago

Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects

Conduit Pharmaceuticals files next generation cocrystal patent for VTAMA® (tapinarof) which the Company believes could be a superior asset with both inflammatory and autoimmune prospectives just as the drug approaches 2027 exclusivity expi... Full story

Yahoo Finance • 7 months ago

Conduit Pharmaceuticals Receives U.S. Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

Conduit secures a composition of matter patent from the USPTO for its lead asset, AZD1656, a Glucokinase Activator targeting autoimmune disorders, positioning the Company for clinical development and strategic partnerships. NAPLES, Fla. a... Full story